Methyltransferase Set7/9 Maintains Transcription and Euchromatin Structure at Islet-enriched Genes

Overview

Journal Diabetes

Specialty Endocrinology

Date 2008 Nov 6

PMID 18984737

Citations 59

Authors

Tye G Deering

Takeshi Ogihara

Anthony P Trace

Bernhard Maier

Raghavendra G Mirmira

Affiliations

Soon will be listed here.

Abstract

Objective: The activation of beta-cell genes, particularly of those encoding preproinsulin, requires an appropriate euchromatin (or "open") DNA template characterized by hypermethylation of Lys4 of histone H3. We hypothesized that this modification is maintained in islet beta-cells by the action of the histone methyltransferase Set7/9.

Research Design And Methods: To identify the role of Set7/9, we characterized its expression pattern and gene regulation and studied its function using RNA interference in both cell lines and primary mouse islets.

Results: Within the pancreas, Set7/9 protein shows striking specificity for islet cells, including alpha- and beta-cells, as well as occasional cells within ducts. Consistent with these findings, the Set7/9 gene promoter contained an islet-specific enhancer located between -5,768 and -6,030 base pairs (relative to the transcriptional start site) that exhibited Pdx1-responsive activation in beta-cells. To study Set7/9 function, we depleted insulinoma cells and primary mouse islets of Set7/9 protein using siRNA. Following siRNA treatment, we observed striking repression of genes involved in glucose-stimulated insulin secretion, including Ins1/2, Glut2, and MafA. These changes in transcription were accompanied by loss of dimethylated H3 Lys4 and RNA polymerase II recruitment, particularly at the Ins1/2 and Glut2 genes. Consistent with these data, depletion of Set7/9 in islets led to defects in glucose-stimulated Ca(2+) mobilization and insulin secretion.

Conclusions: We conclude that Set7/9 is required for normal beta-cell function, likely through the maintenance of euchromatin structure at genes necessary for glucose-stimulated insulin secretion.

Citing Articles

Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development.

Daks A, Parfenyev S, Shuvalov O, Fedorova O, Nazarov A, Melino G Biol Direct. 2024; 19(1):41.

PMID: 38812048 PMC: 11137904. DOI: 10.1186/s13062-024-00484-z.

promotes lateral plate mesoderm formation by modulating the Wnt/β-catenin signaling pathway.

Wang D, Li Y, Xu C, Wang H, Huang X, Jin X iScience. 2023; 26(6):106917.

PMID: 37378343 PMC: 10291335. DOI: 10.1016/j.isci.2023.106917.

Methyltransferase Set7/9 as a Multifaceted Regulator of ROS Response.

Daks A, Shuvalov O, Fedorova O, Parfenyev S, Simon H, Barlev N Int J Biol Sci. 2023; 19(8):2304-2318.

PMID: 37215983 PMC: 10197882. DOI: 10.7150/ijbs.83158.

Methylation of histone H3 lysine 4 is required for maintenance of beta cell function in adult mice.

Vanderkruk B, Maeshima N, Pasula D, An M, McDonald C, Suresh P Diabetologia. 2023; 66(6):1097-1115.

PMID: 36912927 PMC: 10163146. DOI: 10.1007/s00125-023-05896-6.

PDX1 is the cornerstone of pancreatic β-cell functions and identity.

Ebrahim N, Shakirova K, Dashinimaev E Front Mol Biosci. 2023; 9:1091757.

PMID: 36589234 PMC: 9798421. DOI: 10.3389/fmolb.2022.1091757.

References

Ohneda K, Mirmira R, Wang J, Johnson J, German M . The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol Cell Biol. 2000; 20(3):900-11. PMC: 85207. DOI: 10.1128/MCB.20.3.900-911.2000. View

Hohmeier H, Mulder H, Chen G, Prentki M, Newgard C . Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes. 2000; 49(3):424-30. DOI: 10.2337/diabetes.49.3.424. View

Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P . Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell. 2002; 8(6):1207-17. DOI: 10.1016/s1097-2765(01)00405-1. View

Nishioka K, Chuikov S, Sarma K, Erdjument-Bromage H, Allis C, Tempst P . Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 2002; 16(4):479-89. PMC: 155346. DOI: 10.1101/gad.967202. View

Chakrabarti S, James J, Mirmira R . Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J Biol Chem. 2002; 277(15):13286-93. DOI: 10.1074/jbc.M111857200. View

Turner B . Cellular memory and the histone code. Cell. 2002; 111(3):285-91. DOI: 10.1016/s0092-8674(02)01080-2. View

Kwon T, Chang J, Kwak E, Lee C, Joachimiak A, Kim Y . Mechanism of histone lysine methyl transfer revealed by the structure of SET7/9-AdoMet. EMBO J. 2003; 22(2):292-303. PMC: 140100. DOI: 10.1093/emboj/cdg025. View

Xiao B, Jing C, Wilson J, Walker P, Vasisht N, Kelly G . Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature. 2003; 421(6923):652-6. DOI: 10.1038/nature01378. View

Fischle W, Wang Y, Allis C . Histone and chromatin cross-talk. Curr Opin Cell Biol. 2003; 15(2):172-83. DOI: 10.1016/s0955-0674(03)00013-9. View

10.

Chakrabarti S, Francis J, Ziesmann S, Garmey J, Mirmira R . Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. J Biol Chem. 2003; 278(26):23617-23. DOI: 10.1074/jbc.M303423200. View

11.

Yang Z, Chen M, Ellett J, Fialkow L, Carter J, Nadler J . The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation. Transplantation. 2004; 77(1):55-60. DOI: 10.1097/01.TP.0000104844.48064.81. View

12.

Kouskouti A, Scheer E, Staub A, Tora L, Talianidis I . Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell. 2004; 14(2):175-82. DOI: 10.1016/s1097-2765(04)00182-0. View

13.

Bain J, Schisler J, Takeuchi K, Newgard C, Becker T . An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans. Diabetes. 2004; 53(9):2190-4. DOI: 10.2337/diabetes.53.9.2190. View

14.

Ohlsson H, Karlsson K, Edlund T . IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J. 1993; 12(11):4251-9. PMC: 413720. DOI: 10.1002/j.1460-2075.1993.tb06109.x. View

15.

Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H . beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 1998; 12(12):1763-8. PMC: 316911. DOI: 10.1101/gad.12.12.1763. View

16.

Chuikov S, Kurash J, Wilson J, Xiao B, Justin N, Ivanov G . Regulation of p53 activity through lysine methylation. Nature. 2004; 432(7015):353-60. DOI: 10.1038/nature03117. View

17.

Milne T, Hughes C, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y . Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A. 2005; 102(3):749-54. PMC: 545577. DOI: 10.1073/pnas.0408836102. View

18.

Iype T, Francis J, Garmey J, Schisler J, Nesher R, Weir G . Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1: application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes. J Biol Chem. 2005; 280(17):16798-807. DOI: 10.1074/jbc.M414381200. View

19.

Watanabe H, Saito H, Rychahou P, Uchida T, Evers B . Aging is associated with decreased pancreatic acinar cell regeneration and phosphatidylinositol 3-kinase/Akt activation. Gastroenterology. 2005; 128(5):1391-404. DOI: 10.1053/j.gastro.2005.03.016. View

20.

Holland A, Gonez L, Naselli G, MacDonald R, Harrison L . Conditional expression demonstrates the role of the homeodomain transcription factor Pdx1 in maintenance and regeneration of beta-cells in the adult pancreas. Diabetes. 2005; 54(9):2586-95. DOI: 10.2337/diabetes.54.9.2586. View